8 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06851 | WP1 | RLLRLMRLRMLLRM | Derived from RLL peptide | Apoptosis inducing | HDAC inhibition assay | HeLa | Cervical Cancer | IC50 = 0.310±0.064 µM |
| dbacp06852 | WP1 | RLLRLMRLRMLLRM | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | Huh-7 | Liver Cancer | IC50 = 43.74 ± 5.4 μM |
| dbacp06853 | WP1 | RLLRLMRLRMLLRM | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HepG-2 | Liver Cancer | IC50 = 52.23 ± 0.9 μM |
| dbacp06854 | WP1 | RLLRLMRLRMLLRM | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HT-29 | Colon Cancer | IC50 = 54.6 ± 2.1 μM |
| dbacp06855 | WP2 | RLLRLLRLRRLLRL | Derived from RLL peptide | Apoptosis inducing | HDAC inhibition assay | HeLa | Cervical Cancer | IC50 = 0.446±0.095 µM |
| dbacp06856 | WP2 | RLLRLLRLRRLLRL | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | Huh-7 | Liver Cancer | IC50 = 28.12 ± 1.5 μM |
| dbacp06857 | WP2 | RLLRLLRLRRLLRL | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HepG-2 | Liver Cancer | IC50 = 34.05 ± 0.53 μM |
| dbacp06858 | WP2 | RLLRLLRLRRLLRL | Derived from RLL peptide | Apoptosis inducing | Cell Viability assay | HT-29 | Colon Cancer | IC50 = 42.6 ± 4.0 μM |